showed a trendp = 0.258
The LUAD cohort of TCGA also showed a trend of longer OS in CTNNA2-MT patients (log-rank test, p = 0.258), and the trend of longer disease-free survival (DFS) was also observed in CTNNA2-MT patients (log-rank test, p = 0.059) ( Figure 6A ).